» Articles » PMID: 38595822

Engineered Exosomes in Emerging Cell-free Therapy

Overview
Journal Front Oncol
Specialty Oncology
Date 2024 Apr 10
PMID 38595822
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery and use of exosomes ushered in a new era of cell-free therapy. Exosomes are a subgroup of extracellular vesicles that show great potential in disease treatment. Engineered exosomes. with their improved functions have attracted intense interests of their application in translational medicine research. However, the technology of engineering exosomes still faces many challenges which have been the great limitation for their clinical application. This review summarizes the current status of research on engineered exosomes and the difficulties encountered in recent years, with a view to providing new approaches and ideas for future exosome modification and new drug development.

Citing Articles

Advances and challenges in the use of liquid biopsy in gynaecological oncology.

Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.

PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.


Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy.

Zhou W, Yang F, Zhang X Cells. 2024; 13(17.

PMID: 39273000 PMC: 11394047. DOI: 10.3390/cells13171428.


Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment.

Lin H, Zhou J, Ding T, Zhu Y, Wang L, Zhong T Eur J Med Res. 2024; 29(1):350.

PMID: 38943222 PMC: 11212438. DOI: 10.1186/s40001-024-01937-x.

References
1.
Zhang L, Yu D . Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019; 1871(2):455-468. PMC: 6542596. DOI: 10.1016/j.bbcan.2019.04.004. View

2.
Dougherty J, Kumar N, Noor M, Angelos M, Khan M, Chen C . Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis. Front Physiol. 2019; 9:1794. PMC: 6302004. DOI: 10.3389/fphys.2018.01794. View

3.
Hu S, Ma J, Su C, Chen Y, Shu Y, Qi Z . Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis. Acta Biomater. 2021; 135:567-581. DOI: 10.1016/j.actbio.2021.09.003. View

4.
Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y . Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023; 22(1):55. PMC: 10024440. DOI: 10.1186/s12943-023-01759-1. View

5.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View